Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Antifungal activity of KP-103 under evaluation

Nov. 24, 1997

FDA advisory committee recommends approval of Rocephin for AOM

Nov. 24, 1997

Favorable results obtained in pediatric study of Neuprex

Nov. 24, 1997

Takeda reports novel carbapenems

Nov. 24, 1997

New triazole antifungals from Pfizer

Nov. 24, 1997

Floxin recommended for FDA approval

Nov. 21, 1997

AMBI cleared by FDA to commence nisin trials

Nov. 19, 1997

New antifungals from Pola

Nov. 19, 1997

Sankyo isolates A-76356, novel antibacterial agent

Nov. 19, 1997

MiKasome enters phase II for UTI

Nov. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.